Showing results (921-930 of 2,941) with videos related to

Sort By:
Pageof 295
Clinical Hemorheology and Microcirculation|March 11, 2000
Tissular oxygenation and venoarteriolar reflex disturbances in diabetes mellitus: vasoregulator effect of BuflomedilC Le Devehat, T Khodabandehlou, M Vimeux
Clinical Hemorheology and Microcirculation|March 11, 2000
Erythrocytes stored in CPD SAG-mannitol: evaluation of their deformabilityP Izzo, A Manicone, A Spagnuolo, et al.
Clinical Hemorheology and Microcirculation|March 11, 2000
Hemorheological aspects in hypertensive menopausal smoker women treated with female hormonesG Cicco, E Dolce, P Vicenti, et al.
Clinical Hemorheology and Microcirculation|March 11, 2000
Gender difference in rheologic properties of blood and risk of cardiovascular diseasesM V Kameneva, M J Watach, H S Borovetz
Clinical Hemorheology and Microcirculation|March 11, 2000
Modelisation of leukocyte adhesion on a fibrinogen coated surface in static conditionsV Labrador, S Legrand, S Muller, et al.
Clinical Hemorheology and Microcirculation|March 11, 2000
Hemorheological disturbances and characteristic parameters in patients with cerebrovascular diseaseN Antonova, I Velcheva
Clinical Hemorheology and Microcirculation|March 11, 2000
Tissular oxygenation and erythrocyte deformability in haemodialyzed patients using different dialytic membranesG Passavanti, G Cicco, G Baldassarre, et al.
Clinical Hemorheology and Microcirculation|March 11, 2000
Relationship of high-density lipoprotein cholesterol and red blood cell filterability: cross-sectional study of healthy subjectsJ Ejima, T Ijichi, Y Ohnishi, et al.
Clinical Hemorheology and Microcirculation|March 11, 2000
Comparative values of erythrocyte aggregability versus other indices of hemorheological disorders in patients with ischemic brain infarctsG Mchedlishvili, R Shakarishvili, N Momtselidze, et al.
Clinical Hemorheology and Microcirculation|March 11, 2000
Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV studyJ Koscielny, R Latza, A Pruss, et al.
Pageof 295